Needham Maintains Buy on Carlsmed, Raises Price Target to $22
Benzinga Newsdesk 2 hours ago
Analyst RatingsNewsPrice Target
Needham analyst David Saxon maintains Carlsmed (NASDAQ:CARL) with a Buy and raises the price target from $17 to $22.
Needham analyst David Saxon maintains Carlsmed (NASDAQ:CARL) with a Buy and raises the price target from $17 to $22.